Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -444,440 | -440,667 | 681,313 | -96,692 | -153,524 |
| Depreciation Amortization | 14,182 | 1,762 | 10,870 | 14,741 | 15,351 |
| Income taxes - deferred | -36 | N/A | N/A | N/A | N/A |
| Accounts receivable | 1,913 | 6,411 | -25,505 | 10,664 | 4,269 |
| Accounts payable and accrued liabilities | 2,382 | 12,967 | 971 | 2,074 | 518 |
| Other Working Capital | 16,748 | 21,688 | -39,006 | -37,616 | 7,930 |
| Other Operating Activity | 95,964 | 69,158 | 89,571 | 26,415 | 8,432 |
| Operating Cash Flow | $-313,287 | $-328,681 | $718,214 | $-80,414 | $-117,024 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,258 | -26,285 | -11,606 | -9,676 | -6,392 |
| Purchase Of Investment | -987,533 | -1,380,865 | -2,271,250 | -404,425 | -334,659 |
| Sale Of Investment | 1,491,004 | 1,614,036 | 902,920 | 385,292 | 258,651 |
| Investing Cash Flow | $496,213 | $206,886 | $-1,379,936 | $-28,809 | $-82,400 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -250,000 | N/A | N/A | -5,131 | -5,945 |
| Common Stock Issued | 23,396 | 23,355 | 851,966 | 59,522 | 209,563 |
| Other Financing Activity | 146,250 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-80,354 | $23,355 | $851,966 | $54,391 | $203,618 |
| Exchange Rate Effect | 20 | -102 | -101 | -46 | -124 |
| Beginning Cash Position | 96,363 | 194,905 | 4,762 | 59,640 | 55,570 |
| End Cash Position | 198,955 | 96,363 | 194,905 | 4,762 | 59,640 |
| Net Cash Flow | $102,592 | $-98,542 | $190,143 | $-54,878 | $4,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | -313,287 | -328,681 | 718,214 | -80,414 | -117,024 |
| Capital Expenditure | -7,258 | -26,285 | -14,239 | -9,676 | -6,392 |
| Free Cash Flow | -320,545 | -354,966 | 703,975 | -90,090 | -123,416 |